What APDCC is Reading #4

Johnson & Johnson is in talks to acquire the Swiss biotech company, Actelion, which develops drugs for rare diseases such as pulmonary arterial hypertension. Actelion share price has been steadily rising since 2011, with the company reporting 1.8 billion in sales during the first 9 months of 2016. Acquiring Actelion could diversify Johnson & Johnson’s Read more about What APDCC is Reading #4[…]

What APDCC is Reading #3

Will ‘Zero-Rating’ be AT&T’s Achilles heel in buying Time Warner? As AT&T Inc. and Time Warner Inc. seek government approval for their $85 billion megadeal, regulatory scrutiny may impede this merger. AT&T plans to offer customers to stream as much content as they want through its own online TV service, namely DirecTV Now, without it Read more about What APDCC is Reading #3[…]

What APDCC is Reading #2

Biogen Idec (NASDAQ: BIIB) grabbed all the next-day-headlines after officially announcing their exciting phase 1b clinical results in a peer-reviewed journal Nature in September 2016. To trace back, the encouraging story started in 2007, when Biogen in-licensed a recombinant human antibody from Neurimmune, a spin-off from University of Zurich. Neurimmune generated this antibody from their Read more about What APDCC is Reading #2[…]

What APDCC is Reading #1

Qualcomm, a San Diego based semiconductor giant, founded in 1985 has been one of the world’s top 10 chip manufacturers. The company’s primary revenue is through the design and sale of semiconductor chips for tracking devices, mobile and satellite phones, modems, etc. The other major revenue stream for Qualcomm is through the licensing of their patents, which Read more about What APDCC is Reading #1[…]

Interview: Sara Bell about her preparation towards becoming a consultant

Interview: Sara Bell about her preparation towards becoming a consultant   Q) Can you introduce yourself for the readers please? I graduated with a BS in Biochemistry from Tufts University and am now finishing my PhD in Cancer Genetics at UCSD. Q) When and how did you decide on becoming a consultant? Over the years, Read more about Interview: Sara Bell about her preparation towards becoming a consultant[…]

Interview: Hannah Knight about her preparation towards becoming a consultant

Interview: Hannah Knight about her preparation towards becoming a consultant   Q) Can you introduce yourself for the readers please? Hello! I am a PhD student in Biological Sciences. In the 2015-2016 academic year, I was one of the vice presidents of APDCC. Q) When and how did you decide on becoming a consultant?  The Read more about Interview: Hannah Knight about her preparation towards becoming a consultant[…]

Interview: Saralin Davis about her experiences at McKinsey Insight

 Interview: Saralin Davis about her experiences at McKinsey Insight   Q) Can you introduce yourself for the readers please? I did my undergrad at Colby College in Waterville, ME where I majored in Biology and Mathematics and I am currently a sixth year finishing up my PhD in Biomedical Sciences. About half way through my graduate program Read more about Interview: Saralin Davis about her experiences at McKinsey Insight[…]